Modernatx, Inc.

États‑Unis d’Amérique


 
Quantité totale PI 1 258
Rang # Quantité totale PI 1 061
Note d'activité PI 3,8/5.0    1 280
Rang # Activité PI 574
Classe Nice dominante Produits pharmaceutiques, vétéri...

Brevets

Marques

447 111
73 116
318 64
129
 
Dernier brevet 2025 - Polynucleotides encoding cystic ...
Premier brevet 2011 - Engineered nucleic acids and met...
Dernière marque 2025 - CIMTEKVI
Première marque 2010 - MODERNA

Industrie (Classification de Nice)

Derniers inventions, produits et services

2025 P/S vaccines for human use.
P/S Vaccines for human use
P/S Vaccines for human use
P/S Vaccines
Invention Compositions and methods for detecting dsrna. The present disclosure relates generally to antibo...
2024 Invention Betacoronavirus mrna vaccines. The disclosure relates to ribonucleic acid (RNA) vaccines and com...
Invention Betacorona virus mrna vaccines. The disclosure relates to ribonucleic acid (RNA) vaccines and co...
Invention Polynucleotides encoding glucose-6-phosphatase for the treatment of glycogen storage disease. Th...
Invention Polynucleotides encoding cystic fibrosis transmembrane conductance regulator for the treatment of...
Invention Concatemeric peptide epitope rnas. The invention relates to concatemeric peptide epitope RNAs, a...
Invention Rna polymerase variants for co-transcriptional capping. The present disclosure provides RNA poly...
Invention Peg lipids and uses thereof. The present disclosure in part provides compounds (i.e., PEG lipids...
Invention Immunoglobulin a protease polypeptides, polynucleotides, and uses thereof. This disclosure relate...
Invention Humanized anti-cd3 binding molecules and uses thereof. Described herein are humanized anti-CD3 an...
Invention Polynucleotides encoding phenylalanine hydroxylase for the treatment of phenylketonuria. in vivoi...
Invention Chemical stability of mrna. Some aspects of the disclosure relate to mRNAs in which a higher prop...
Invention Delivery and formulation of engineered nucleic acids. Provided are formulations, compositions an...
Invention Modified nucleosides, nucleotides, and nucleic acids, and uses thereof. The present disclosure p...
Invention Human cytomegalovirus rna vaccines. The disclosure describes HCMV ribonucleic acid (RNA) vaccine...
Invention C-met binding antibodies, nucleic acids encoding same, and methods of use. Described herein are a...
Invention Rna cancer vaccines. The disclosure relates to cancer ribonucleic acid (RNA) vaccines, as well a...
Invention Nucleic acid vaccines. The invention relates to compositions and methods for the preparation, ma...
Invention Respiratory syncytial virus vaccine. The disclosure relates to respiratory syncytial vims (RSV) ...
Invention Varicella-zoster virus mrna vaccine. Provided herein are optimized messenger ribonucleic acid (mR...
Invention Vlp enteroviral vaccines. Aspects of the disclosure relate to compositions of messenger RNA vacci...
Invention Hiv rna vaccines. Provided herein are methods and compositions for inducing in a subject a broad...
Invention Mers-cov mrna vaccines. Aspects of the present disclosure relate to mRNA vaccines encoding Middle...
Invention Modified polynucleotides for the production of biologics and proteins associated with human disea...
Invention Messenger ribonucleic acids for enhancing immune responses and methods of use thereof. The discl...
Invention Sars-cov-2 t cell vaccines. Some aspects of the disclosure relate to mRNA vaccines encoding chime...
Invention Compounds and compositions for delivery of therapeutic agents. The disclosure features novel lipi...
Invention Stabilized flavivirus vaccines. Provided herein are engineered flavivirus heterotetrameric protei...
Invention Terminally modified rna. The invention relates to compositions and methods for the manufacture a...
Invention Modified polynucleotides for the production of oncology-related proteins and peptides. The inven...
Invention Varicella zoster virus (vzv) vaccine. Aspects of the disclosure relate to nucleic acid vaccines....
2023 Invention Modified polynucleotides for the production of secreted proteins. The invention relates to compo...
Invention Continuous precipitation for mrna purification. Aspects of the disclosure relate to methods of p...
Invention In vitro transcription dna purification and recycling. Provided herein are methods of preparing ...
2022 Invention Processes for preparing lipid nanoparticles. The present disclosure provides processes for contr...
Invention Determination of encapsulation efficiency of lipid nanoparticles. Methods of assessing the perce...
Invention Compounds and compositions for delivery of therapeutic agents. The disclosure features novel lip...
Invention Compositions for the delivery of payload molecules to airway epithelium. The present disclosure ...
Invention Methods of purifying dna for gene synthesis. Provided herein are methods of purifying nucleic ac...
Invention Custom bacterial strain for recombinant protein production. Described here are genetically modif...
Invention Markerless dna production. Provided herein are genetically modified microorganisms comprising a ...
Invention Polynucleotides encoding relaxin for the treatment of fibrosis and/or cardiovascular disease. Th...
Invention Mrnas encoding chimeric metabolic reprogramming polypeptides and uses thereof. The disclosure fe...
Invention Extraction-less reverse phase (rp) chromatography of mrna encapsulated in lipid nanoparticles for...
Invention Polynucleotides encoding glucose-6-phosphatase for the treatment of glycogen storage disease type...